BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 210,587,372
- Total 13F shares
- 174,343,886
- Share change
- -5,481,683
- Total reported value
- $1,077,260,403
- Put/Call ratio
- 112%
- Price per share
- $6.18
- Number of holders
- 238
- Value change
- -$26,171,848
- Number of buys
- 122
- Number of sells
- 107
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
8.8%
|
18,440,729
|
$93,678,903 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
17,676,767
|
$89,797,977 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
8.3%
|
17,477,344
|
$88,784,908 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.2%
|
13,050,000
|
$66,294,000 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4.8%
|
10,126,176
|
$51,440,974 | — | 31 Mar 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
3.1%
|
6,527,491
|
$33,159,654 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.4%
|
4,995,000
|
$25,374,600 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
4,400,271
|
$22,356,476 | — | 31 Mar 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
4,099,484
|
$20,825,379 | — | 31 Mar 2024 | |
| RP Management, LLC |
13F
|
Company |
1.8%
|
3,846,154
|
$19,538,462 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.7%
|
3,496,256
|
$17,760,980 | — | 31 Mar 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.6%
|
3,453,908
|
$17,546,000 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
1.6%
|
3,379,577
|
$17,168,251 | — | 31 Mar 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.4%
|
2,884,619
|
$14,653,863 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.2%
|
2,619,861
|
$13,308,893 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.2%
|
2,473,412
|
$12,564,933 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
2,335,191
|
$11,862,771 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
1.1%
|
2,274,775
|
$11,555,857 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
1%
|
2,151,545
|
$10,929,849 | — | 31 Mar 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
1%
|
2,105,459
|
$10,695,732 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.95%
|
2,008,045
|
$10,200,869 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.91%
|
1,925,365
|
$9,780,854 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.88%
|
1,843,936
|
$9,367,195 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.87%
|
1,835,076
|
$9,322,186 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.87%
|
1,830,169
|
$9,297,259 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
1,805,175
|
$9,170,290 | — | 31 Mar 2024 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.83%
|
1,749,448
|
$8,887,196 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
1,731,803
|
$8,797,559 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.77%
|
1,616,244
|
$8,210,520 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.76%
|
1,590,380
|
$8,079,000 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.75%
|
1,574,641
|
$7,999,176 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.75%
|
1,569,782
|
$7,974,493 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.68%
|
1,432,427
|
$7,276,729 | — | 31 Mar 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.66%
|
1,400,000
|
$7,112,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.65%
|
1,366,167
|
$6,940,128 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.53%
|
1,116,957
|
$5,674,142 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.53%
|
1,116,678
|
$5,672,725 | — | 31 Mar 2024 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.52%
|
1,094,168
|
$5,558,373 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.48%
|
1,006,029
|
$5,110,627 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.47%
|
999,316
|
$5,076,751 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.47%
|
996,555
|
$5,062,500 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
967,722
|
$4,916,028 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.38%
|
800,000
|
$4,064,000 | — | 31 Mar 2024 | |
| Caligan Partners LP |
13F
|
Company |
0.36%
|
758,502
|
$3,853,190 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.36%
|
750,694
|
$3,813,526 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.36%
|
748,794
|
$3,803,874 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.34%
|
719,442
|
$3,654,765 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.34%
|
709,500
|
$3,604,260 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
689,708
|
$3,503,717 | — | 31 Mar 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.32%
|
675,000
|
$3,429,000 | — | 31 Mar 2024 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q2 2024
As of 30 Jun 2024,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
238 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
174,343,886 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ALKEON CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Caligan Partners LP, and Nuveen Asset Management, LLC.
This page lists
238
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
235
Q2 2024 holders
238
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.